Takagi, Seiji http://orcid.org/0000-0001-6267-1641
Mandai, Michiko
Hirami, Yasuhiko
Sugita, Sunao
Takahashi, Masayo
Kurimoto, Yasuo
Article History
Received: 4 December 2017
Accepted: 6 June 2018
First Online: 12 July 2018
Conflicts of interest
: S. Takagi, Grant (Alcon, AMO, HOYA, Senju), Lecture fee (Alcon); M. Mandai, Grant (Sumitomo Dainippon Pharma, Tomey), Consultant fees (Alcon, Bayer, Healios, Otsuka, Santen, Senju); Y. Hirami, Grant (Alcon, AMO, HOYA, Senju), Lecture fees (Alcon, Bayer, Santen); S. Sugita, None; M. Takahashi, Grant (Healios, Hitachi, Nichirei Biosciences, Nitta Biolab, Sagawa, Sanplatec, Santen, Shibuya, Sumitomo Dainippon Pharma, Tomey), Consultant fees (Alcon, Astellas, DAI-DAN, Eisai, Healios, Novaris, Sysmex, Takeda, Topcon, Toray); Y. Kurimoto, Grant (Alcon, HOYA, Santen, Senju), Consultant fees (Alcon, AMO, Bayer, Cannon, Kowa, Otsuka, Pfizer, Santen, Senju).